World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26508
World Ranking
13232
National Ranking
6740

Research.com Recognitions

  • 1982 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Saul A. Rosenberg is affiliated with Stanford University in the United States. Their research primarily falls within the field of Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Radiation, and Pediatrics, Perinatology and Child Health.

The topics covered by Rosenberg's work reflect a concentration on lymphoma diagnosis and treatment, lung cancer treatments and mutations, viral-associated cancers and disorders, advanced radiotherapy techniques, pharmaceutical studies and practices, microscopic colitis, and biosimilars and bioanalytical methods.

Notable recent publications by Rosenberg include:

  • Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation, 2020, Leukemia & lymphoma/Leukemia and lymphoma
  • Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies), 2020, International Journal of Radiation Oncology*Biology*Physics
  • RWD161 Therapeutic Drug Monitoring (TDM) of Infliximab Is Associated with Lower Biologic Switch & Expenditures Compared to No-TDM Cohort of IBD Patients Based on 12 to 48-Month Real-World Outcomes from a US Community GI Practice, 2024, Value in Health
  • Unburied polytetrafluoroethylene scleral suture erosions and failure of pericardial graft revision, 2024, American Journal of Ophthalmology Case Reports

Frequent co-authors who have collaborated with Rosenberg include Rie von Eyben, Ranjana H. Advani, Richard T. Hoppe, Christopher R. Weil, and Yushen Qian.

Most of Rosenberg's publications appear in venues such as Leukemia & lymphoma/Leukemia and lymphoma, International Journal of Radiation Oncology*Biology*Physics, Value in Health, and American Journal of Ophthalmology Case Reports.

Rosenberg has been recognized with several honors including being named a Member of the National Academy of Medicine in 1982 and membership in the Association of American Physicians.

Best Publications

  • Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

    T A Lister;D Crowther;S B Sutcliffe;E Glatstein

  • Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

    Gwendolyn Fyfe;Richard I. Fisher;Steven A. Rosenberg;Mario Sznol

  • Lymphosarcoma: a review of 1269 cases.

    Saul A. Rosenberg;Henry D. Diamond;Bernard Jaslowitz;Lloyd F. Craver

  • The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

    Sandra J. Horning;Saul A. Rosenberg

  • Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases

    Stephen E. Jones;Zvi Fuks;Malcolm Bull;Marshall E. Kadin

  • Hematologic Neoplasia in Patients Treated for Hodgkin's Disease

    Coleman Cn;Williams Cj;Flint A;Glatstein Ej

  • The value of laparotomy and splenectomy in the staging of Hodgkin's disease.

    Eli Glatstein;Henry S. Kaplan;James M. Guernsey;Saul A. Rosenberg

  • Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

    John G. Krikorian;Jerome S. Burke;Saul A. Rosenberg;Henry S. Kaplan

  • Report of the Committee on the Staging of Hodgkin's Disease

    Saul A. Rosenberg

  • Female Reproductive Potential after Treatment for Hodgkin's Disease

    Sandra J. Horning;Richard T. Hoppe;Henry S. Kaplan;Saul A. Rosenberg

  • Central Nervous System Involvement in non-Hodgkin 's Lymphoma: An Analysis of 105 Cases

    F. Roy Mackintosh;Thomas V. Colby;William J. Podolsky;Jerome S. Burke

  • Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

    Sandra J. Horning;Richard T. Hoppe;Sheila Breslin;Nancy L. Bartlett

  • The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

    RT Hoppe;CN Coleman;RS Cox;SA Rosenberg

  • Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

    Thomas C. Merigan;Karol Sikora;James H. Breeden;Ronald Levy

  • No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

    Carol S. Portlock;Saul A. Rosenberg

  • Evidence for an orderly progression in the spread of Hodgkin's disease.

    Saul A. Rosenberg;Henry S. Kaplan

  • Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease

    Alan R. Yuen;Saul A. Rosenberg;Richard T. Hoppe;Jerry D. Halpern

  • Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy

    Ranjana Advani;Saul A. Rosenberg;Sandra J. Horning

  • Histologic conversion in the non-Hodgkin's lymphomas.

    Brian Acker;Richard T. Hoppe;Thomas V. Colby;Richard S. Cox

  • The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

    Saul A. Rosenberg;Henry S. Kaplan

Frequent Co-Authors

Richard T. Hoppe
Richard T. Hoppe Stanford University
Henry S. Kaplan
Henry S. Kaplan Stanford University
Ranjana H. Advani
Ranjana H. Advani Stanford University
Sarah S. Donaldson
Sarah S. Donaldson Stanford University
Roger A. Warnke
Roger A. Warnke Stanford University
Ronald F. Dorfman
Ronald F. Dorfman Stanford University
George P. Canellos
George P. Canellos Harvard University
Thomas C. Merigan
Thomas C. Merigan Stanford University
Yasodha Natkunam
Yasodha Natkunam Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring your options beyond a traditional MD degree can open new doors in the healthcare field. Online programs provide greater flexibility, allowing students and busy professionals to balance their studies with work or personal commitments.

For those interested in healthcare leadership, pursuing a cheapest mha programs online healthcare can lead to roles in hospital administration, health policy, or clinical management. These affordable master's programs are designed for future leaders who want to improve systems of care.

Nursing professionals looking to advance further might consider cheap dnp online programs, which focus on the highest level of nursing practice. A Doctor of Nursing Practice (DNP) can prepare you for specialized, high-responsibility positions in clinical or academic settings.

Future pharmacists now have the option to enroll in online pharmacist programs. These online PharmD degrees are tailored for both aspiring pharmacists and professionals seeking career advancement.

Additionally, if you have an interest in the data and technology side of healthcare, an online bachelor's in health information management prepares you for careers in electronic health records, information security, and health data analysis.

Best Scientists Citing Saul A. Rosenberg

Trending Scientists

Recently Published Articles